Which Clinicopathologic Parameters Suggest Primary Resistance to Palbociclib in Combination With Letrozole as the First-Line Treatment for Hormone Receptor-Positive, HER2-Negative...

by Ji-Yeon Kim, Jung Min Oh, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Young-Hyuck Im
Published 2021-10-01

Lymphocyte-activating gene 3 expression in tumor cells predicts immune checkpoint inhibitor response in triple negative breast cancer

by Ji-Yeon Kim, Ji-Yeon Kim, Jeehyun Kim, Eun Yoon Cho, Yeon Hee Park, Yeon Hee Park, Jin Seok Ahn, Jin Seok Ahn, Kyoung-Mee Kim, Kyoung-Mee Kim, Young-Hyuck Im, Young-Hyuck Im, Young-Hyuck Im
Published 2023-03-01

TP53 mutations predict poor response to immunotherapy in patients with metastatic solid tumors

by Ji‐Yeon Kim, Jaeyun Jung, Kyoung‐Mee Kim, Jeeyun Lee, Young‐Hyuck Im
Published 2023-06-01

Real World Experience of Second-Line Treatment Strategies after Palbociclib and Letrozole: Overall Survival in Metastatic Hormone Receptor-Positive Human Epidermal Growth Factor Re...

by Ji-Yeon Kim, Junghoon Shin, Jin Seok Ahn, Yeon Hee Park, Young-Hyuck Im
Published 2023-06-01

Improved Prediction of Survival Outcomes Using Residual Cancer Burden in Combination With Ki-67 in Breast Cancer Patients Underwent Neoadjuvant Chemotherapy

by Ji-Yeon Kim, Ji-Yeon Kim, Jung Min Oh, Se Kyung Lee, Jonghan Yu, Jeong Eon Lee, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Yeon Hee Park, Yeon Hee Park, Yeon Hee Park, Jin Seok Ahn, Kyunga Kim, Kyunga Kim, Kyunga Kim, Young-Hyuck Im, Young-Hyuck Im, Young-Hyuck Im
Published 2022-06-01

Clinical Characteristics of Korean Breast Cancer Patients Who Carry Pathogenic Germline Mutations in Both BRCA1 and BRCA2: A Single-Center Experience

by Joon Young Hur, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Jiyun Lee, Minsuk Kwon, Yeon Hee Park
Published 2020-05-01

Multimodal deep learning models for the prediction of pathologic response to neoadjuvant chemotherapy in breast cancer

by Sunghoon Joo, Eun Sook Ko, Soonhwan Kwon, Eunjoo Jeon, Hyungsik Jung, Ji-Yeon Kim, Myung Jin Chung, Young-Hyuck Im
Published 2021-09-01

Clinical activity of fulvestrant in metastatic breast cancer previously treated with endocrine therapy and/or chemotherapy

by Mi Hwa Heo, Hee Kyung Kim, Hansang Lee, Ji-Yeon Kim, Jin-Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Published 2019-09-01

Evaluation of Pathologic Complete Response in Breast Cancer Patients Treated with Neoadjuvant Chemotherapy: Experience in a Single Institution over a 10-Year Period

by Misun Choi, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im, Seok Jin Nam, Soo Youn Cho, Eun Yoon Cho
Published 2017-01-01

The Impacts of Inclusion in Clinical Trials on Outcomes among Patients with Metastatic Breast Cancer (MBC).

by Ji Yun Lee, Sung Hee Lim, Min-Young Lee, Hae Su Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Published 2016-01-01

The Tumor–Fat Interface Volume of Breast Cancer on Pretreatment MRI Is Associated with a Pathologic Response to Neoadjuvant Chemotherapy

by Hwan-ho Cho, Minsu Park, Hyunjin Park, Eun Sook Ko, Na Young Hwang, Young-Hyuck Im, Kyounglan Ko, Sung Hoon Sim
Published 2020-11-01

Local Laboratory Testing of Germline BRCA Mutations vs. Myriad: A Single-Institution Experience in Korea

by Joohyun Hong, Jiyun Lee, Minsuk Kwon, Ji-Yeon Kim, Jong-Won Kim, Jin Seok Ahn, Young-Hyuck Im, Yeon Hee Park
Published 2021-02-01

Impact of high dose radiotherapy for breast tumor in locoregionally uncontrolled stage IV breast cancer: a need for a risk-stratified approach

by Nalee Kim, Haeyoung Kim, Won Park, Won Kyung Cho, Tae Gyu Kim, Young-Hyuck Im, Jin Seok Ahn, Yeon Hee Park, Ji-Yeon Kim
Published 2023-10-01

A Retrospective Exploratory Analysis for Serum Extracellular Vesicles Reveals APRIL (TNFSF13), CXCL13, and VEGF-A as Prognostic Biomarkers for Neoadjuvant Chemotherapy in Triple-Ne...

by Hae Hyun Jung, Ji-Yeon Kim, Eun Yoon Cho, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im
Published 2023-10-01

Comprehensive Clinical Characterization of Decade-Long Survivors of Metastatic Breast Cancer

by Junghoon Shin, Ji-Yeon Kim, Jung Min Oh, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Won Park, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im
Published 2023-09-01

Elevated Level of Nerve Growth Factor (NGF) in Serum-Derived Exosomes Predicts Poor Survival in Patients with Breast Cancer Undergoing Neoadjuvant Chemotherapy

by Hae Hyun Jung, Ji-Yeon Kim, Eun Yoon Cho, Jung Min Oh, Jeong Eon Lee, Seok Won Kim, Seok Jin Nam, Yeon Hee Park, Jin Seok Ahn, Young-Hyuck Im
Published 2021-10-01

Body Mass Index with Tumor 18F-FDG Uptake Improves Risk Stratification in Patients with Breast Cancer.

by Seung Hyup Hyun, Hee Kyung Ahn, Joo Hee Lee, Joon Young Choi, Byung-Tae Kim, Yeon Hee Park, Young-Hyuck Im, Jeong Eon Lee, Seok Jin Nam, Kyung-Han Lee
Published 2016-01-01

Clinical implication of tumor mutational burden in patients with HER2-positive refractory metastatic breast cancer

by Song Ee Park, Kyunghee Park, Eunjin Lee, Ji-Yeon Kim, Jin Seok Ahn, Young-Hyuck Im, Choonghoon Lee, Hun Jung, Soo Youn Cho, Woong-Yang Park, Razvan Cristescu, Yeon Hee Park
Published 2018-08-01

Health-related quality of life in premenopausal women with hormone-receptor-positive, HER2-negative advanced breast cancer treated with ribociclib plus endocrine therapy: results f...

by Nadia Harbeck, Fabio Franke, Rafael Villanueva-Vazquez, Yen-Shen Lu, Debu Tripathy, Louis Chow, Govind K Babu, Young-Hyuck Im, David Chandiwana, Anil Gaur, Brad Lanoue, Karen Rodriguez-Lorenc, Aditya Bardia
Published 2020-07-01

Clinical Features and Outcomes of Invasive Breast Cancer: Age-Specific Analysis of a Modern Hospital-Based Registry

by Ji-Yeon Kim, Danbee Kang, Seok Jin Nam, Seok Won Kim, Jeong Eon Lee, Jong Han Yu, Se Kyung Lee, Young-Hyuck Im, Jin Seok Ahn, Eliseo Guallar, Juhee Cho, Yeon Hee Park
Published 2019-07-01